Dexcom (Nasdaq:DXCM) has issued an update related to a recall for its continuous glucose monitor (CGM) components.

Abbott (NYSE:ABT) today reported Street-beating second-quarter results that included significant growth in its Diabetes ...

(NYSE:JNJ) announced today that the FDA granted priority review to a new drug application (NDA) for its TAR-200.

Sequel built its twiist system on underlying drug delivery technology developed by DEKA R&D. Dean Kamen, co-founder of Sequel ...

LifeScan announced that it entered into a restructuring support agreement and, to implement it, filed for chapter 11 bankruptcy.